ArticleHepatology international2024

Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis.

Yangyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.